HDAC9 and colorectal cancer: Our results showed that MPT0G236 is a novel pan-HDAC inhibitor that displayed a meaningful antiproliferative effect in colorectal cancer cells that resulted in cell cycle G2/M arrest and caspase-dependent apoptosis.